DE69910787D1 - Neuartige, pharmazeutisch aktive verbindung - Google Patents

Neuartige, pharmazeutisch aktive verbindung

Info

Publication number
DE69910787D1
DE69910787D1 DE69910787T DE69910787T DE69910787D1 DE 69910787 D1 DE69910787 D1 DE 69910787D1 DE 69910787 T DE69910787 T DE 69910787T DE 69910787 T DE69910787 T DE 69910787T DE 69910787 D1 DE69910787 D1 DE 69910787D1
Authority
DE
Germany
Prior art keywords
new
active pharmaceutical
6alkyl
optionally substituted
connection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69910787T
Other languages
English (en)
Other versions
DE69910787T2 (de
Inventor
Kostas Karabelas
Matti Lepistoe
Peter Sjoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69910787D1 publication Critical patent/DE69910787D1/de
Application granted granted Critical
Publication of DE69910787T2 publication Critical patent/DE69910787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69910787T 1998-07-13 1999-06-23 Neuartige, pharmazeutisch aktive verbindung Expired - Fee Related DE69910787T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802538A SE9802538D0 (sv) 1998-07-13 1998-07-13 New pharmaceutically active compounds
SE9802538 1998-07-13
PCT/SE1999/001145 WO2000002877A2 (en) 1998-07-13 1999-06-23 New pharmaceutically active compounds

Publications (2)

Publication Number Publication Date
DE69910787D1 true DE69910787D1 (de) 2003-10-02
DE69910787T2 DE69910787T2 (de) 2004-07-08

Family

ID=20412083

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910787T Expired - Fee Related DE69910787T2 (de) 1998-07-13 1999-06-23 Neuartige, pharmazeutisch aktive verbindung

Country Status (7)

Country Link
EP (1) EP1095039B1 (de)
JP (1) JP2002531382A (de)
AT (1) ATE248163T1 (de)
AU (1) AU4944899A (de)
DE (1) DE69910787T2 (de)
SE (1) SE9802538D0 (de)
WO (1) WO2000002877A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030084444A (ko) 2002-04-26 2003-11-01 주식회사 파나진 Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
EP1799639B1 (de) 2004-10-12 2013-09-04 Glenmark Pharmaceuticals S.A. Neue dipeptidylpeptidase-iv-inhibitoren, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
UA90690C2 (ru) * 2004-10-12 2010-05-25 Гленмарк Фармасьютикалс С.А. Ингибиторы дипептидилпептидазы iv, процесс их получения и фармацевтическая композиция, которая их содержит (варианты)
US9708350B2 (en) 2014-12-04 2017-07-18 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator
JP6460937B2 (ja) * 2014-12-04 2019-01-30 信越化学工業株式会社 末端にアミノ基を有するポリアルキレングリコール誘導体の製造方法
US10377775B2 (en) 2014-12-04 2019-08-13 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
AR017200A1 (es) * 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos

Also Published As

Publication number Publication date
WO2000002877A2 (en) 2000-01-20
JP2002531382A (ja) 2002-09-24
EP1095039B1 (de) 2003-08-27
ATE248163T1 (de) 2003-09-15
DE69910787T2 (de) 2004-07-08
EP1095039A2 (de) 2001-05-02
WO2000002877A3 (en) 2000-04-13
SE9802538D0 (sv) 1998-07-13
AU4944899A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
SE9504661D0 (sv) New compounds
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
ES2145913T3 (es) Inhibidores de metaloproteasas.
SE8300736D0 (sv) Novel pharmacologically active compounds
BR0109703A (pt) Derivados de piperazina
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
EA200200571A1 (ru) Новая композиция и ее применение
SE9900961D0 (sv) Novel compounds
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
IT1285770B1 (it) Composti corticoidei
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE68913762D1 (de) Diarylverbindungen als antiatherosklerotische Mittel.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
NZ240481A (en) Aminosulphonyl urea derivatives and pharmaceutical compositions
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
SE9902387D0 (sv) New pharmaceutically active compounds
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
SE9704770D0 (sv) New use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee